Pseudo-hypoaldosteronisms;Pseudo-hypoaldostéronismes

Presse Medicale

Volumn 33, Issue 2, 2004, Pages 123-129

  Vantyghem, Marie Christine ^a   Perimenis, Pierrette ^a   Wemeau, Jean Louis ^a  

^a LILLE UNIVERSITY HOSPITAL   (France)

Author keywords

[No Author keywords available]

Indexed keywords

ADENOSINE TRIPHOSPHATASE (POTASSIUM SODIUM); ALDOSTERONE; AMILORIDE; CHLORIDE; HYDROGEN; MINERALOCORTICOID; MINERALOCORTICOID RECEPTOR; PHOSPHOTRANSFERASE; POTASSIUM; SODIUM; SODIUM CHANNEL; SYNTAXIN; UNCLASSIFIED DRUG; WNK KINASE;

AUTOSOMAL DOMINANT DISORDER; AUTOSOMAL RECESSIVE DISORDER; BLOOD PRESSURE MEASUREMENT; BLOOD PRESSURE REGULATION; CLINICAL FEATURE; COLON RESECTION; CORRELATION ANALYSIS; DIFFERENTIAL DIAGNOSIS; DISEASE ASSOCIATION; DISEASE CLASSIFICATION; DISEASE SEVERITY; ELECTROLYTE BALANCE; FAMILIAL DISEASE; GENE LOCATION; GENE MUTATION; GORDON SYNDROME; HORMONE RESISTANCE; HUMAN; HYPERKALEMIA; HYPERTENSION; HYPOTENSION; ILEOSTOMY; KALIURESIS; KIDNEY DISEASE; KIDNEY TUBULE ACIDOSIS; LUNG DISEASE; PATHOPHYSIOLOGY; PLASMA RENIN ACTIVITY; PSEUDOHYPOALDOSTERONISM; REVIEW; SALT LOSING NEPHRITIS; SIGNAL TRANSDUCTION; SODIUM DEPLETION; SYMPTOM;

EID: 0842285329     PISSN: 07554982     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0755-4982(04)98501-6     Document Type: Short Survey

References (46)

1. Cogan, M, Arieff I. Sodium wasting, acidosis and hyperkaliemia induced by methicillin interstitial nephritis. Am J Med 1978; 64: 500-8.
2. Uribarri J, Oh S, Butt Carrol Jpseudohypoaldosteronism following kidney transplantation. Nephron 1982; 31: 368-71.
3. Escribano-Burgos C, Lopes-D'herce'cid J, Sala Juaniz I, Dorao Martinez-Romilio P, Delgado-Dominguez MA, Espinosa Roman L. Salt losing tubulopathy secondary to urinary infection: a form of transitory pseudohypoaldosteronism An Esp Pediat 1989; 30: 404-6.
4. Rodriguez-Soriano J, Vallo A, Qunitella MJ, Oliveros R, Ube Tagoyena M. Normokaliemic pseudohypoaldosteronism is present in children with acute pyelonephritis. Act Pediat 1992; 81: 402-5.
5. Eisenstein B, Davidovitz M, Garty BZ, Schmueli D, Ussim A, Stark H. Severe tubular resistance to aldosterone in a child with familial juvenile nephrolithiasis. Pediat Nephrol 1992; 3: 57-61.
6. Nieto J, Gutierrez-Millet V, Gutierrez-Rodero F et al. Pseudohypoaldosteronism associated with chronic intersticiel nephropathy. Rev Clin Esp 1995; 1777: 290-5.
7. Schoen EJ, Bhatia S, Ray GT, Clapp W, To TT. Transient pseudohypoaldosteronism with hyponatremiahyperkalemia in infant urinary tract infection. J Urol 2002; 167: 680-2.
8. Clarke AM, Chirnside A, Hill GL, Pope G, Stewart MK. Chronic dehydration and sodium depletion in patients with established ileostomies. Lancet 1967; 2: 740-4.
9. Hill GI, Mair WS, Goligher JC. Impairment of ileostomy adaptation in patients after ileal resectrion. Gut 1974; 62: 720-4.
10. Turnberg LA, Morris AI, Hawker PC, Herman KJ, Schields RA, Horth CE. Intracellular electrolyte depletion in patients with ileostomies. Gut 1978; 19: 63-8.
11. Ladefoged K, Olgaard K. Fluid and electrolyte absorption and renin-angiotensin aldosterone axis in patients with severe short-bowel syndrome. Scand J Gastroenterol 1979; 14: 729-35.
12. Ladefoged K, Olgaard K. Sodium homeostasis after short-bowel resection. Scand J Gastroenterol 1985; 20: 631-7.
13. Vantyghem MC, Hober C, Evrard A et al. Transient pseudo-hypoaldosteronism following resection of the ileum: normal level of lymphocytic aldosterone receptors outside the acute phase. J Endocrinol Invest 1999; 22: 122-7
14. Cheek B, Perry W. A salt wasting syndrome in infancy. Arch Dis Child 1958; 33: 252-61
15. Oberfield E, Levine S, Carey M, Bejar R, New I, Pseudohypoaldosteronism: Multiple target organ untrespionsiveness to mineralocorticoid hormones. J Clin Endocrinol Metab 1979; 48: 228-36.
16. Espinasse-Holder M, Vanderbecken S, Cartigny M, Stuckens C, Weill J. Type Ib Pseudohypoaldosteronism de type 1b: aspects cliniques et problèmes nosologiques. À propos of 3 cas. Arch Pediatr 1999; 6: 1077-80.
17. Kerem E, Bistritzer T, Hanukoglu A et al. Pulmonary epithelial sodium-channel dysfunction and excess airway liquid in pseudohypoaldosteronism. N Engl J Med 1999; 341: 156-62.
18. Armanini D, Kuhnle U, Strasser T. Aldosterone receptor deficiency in pseudohypoaldosteronism. N Engl J Med 1985; 313: 1178
19. Kuhnle U, Keller U, Armanini D, Funder J, Krozowski Z. Immunofluorescence of mineralocorticoid receptors in peripheral lymphocytes: presence of receptor-like activity in patients with the autosomal dominant form of pseudohypoaldosteronism, and its absence in the recessive form. J Steroid Biochem Mol Biol 1994; 51: 267-73.
20. Arai K, Tsigos C, Suzuki Y et al. Physiological and molecular aspects of mineralocorticoid receptor action in pseudohypoaldosteronism: a responsiveness test and therapy. J Clin Endocrinol Metab 1994; 79: 1019-23.
21. Zennaro MC, Borensztein P, Jeunemaitre X, Armanini D, Soubrier F. No alteration in the primary structure of the mineralocorticoid receptor in a family with pseudohypoaldosteronism. J Clin Endocrinol Metab 1994; 79: 32-8.
22. Arai K, Tsigos C, Suzuki Y et al. No apparent mineralocorticoid receptor defect in a series of sporadic cases of pseudohypoaldosteronism. J Clin Endocrinol Metab 1995; 80: 814-17.
23. Geller DS, Rodriguez-Soriano J, Vallo-boado A et al. Mutations in the mineralocorticoid receptor gene cause autosomal dominant pseudohypoaldosteronism type 1. Nat Genet 1998; 19: 279-81.
24. Tajima T, Kitagawa H, Yokoya S et al. A novel missense mutation of mineralocorticoid receptor gene in one Japanese family with a renal form of pseudohypoaldosteronism type 1. J Clin Endocrinol Metab 2000; 85: 4690-4.
25. Viemann M, Peter M, Lopez-Siguero JP, Simic-Schleicher G, Sippell WG. Evidence for genetic heterogeneity of pseudohypoaldosteronism type 1: identification of a novel mutation in the human mineralocorticoid receptor in one sporadic case and no mutations in two autosomal dominant kindreds. J Clin Endocrinol Metab 2001; 86: 2056-9.
26. Chang SS, Grunder S, Hanukoglu A. Mutations in subunits of the epithelial sodium channel cause salt wasting with hyperkaliemic acidosis, pseudohypoaldosteronism type 1. Nat Genet 1996; 12: 248-53
27. Strautnieks SS, Thompson RJ, Gardiner RM, Chung E. A novel splice-site mutation in the gamma subunit of the epithelial sodium channel gene in three pseudohypoaldosteronism type 1 families. Nat Genet 1996; 13: 248-50.
28. Shimkets RA, Warnock DG, Bositis CM et al. Liddle's syndrome: heritable human hypertension caused by mutations in the beta subunit of the epithelial sodium channel. Cell 1994; 79: 407-14.
29. Snyder PM. The epithelial Na+ channel: cell surface insertion and retrieval in Na+ homeostasis and hypertension. Endocr Rev 2002; 23: 258-75.
30. Arai K, Nakagomi Y, Iketani M, et al. Functional polymorphisms in the mineralocorticoid receptor and amiloride-sensitive sodium channel genes in a patient with sporadic pseudohypoaldosteronism. Hum Genet 2003; 112: 91-7
31. Farfel Z, rosenthal T, Shibolet S, Iena A, Gafni J. Familial hyperkalemia and hypertension. Harefuah 1976; 91: 390-2
32. Achard JM, Disse-Nicodeme S, Fiquet-Kempf B, Jeunemaitre X. Phenotypic and genetic heterogeneity of familial hyperkalemic hypertension (Gordon syndrome). Clin Exp Pharmacol Physiol 2001; 28: 1048-52.
33. Mayan H, Vered I, Mouallem M, Tzadok-Witkon M, Pauzner R, Farfel Z. Pseudohypoaldosteronism type II: marked sensitivity to thiazides, hypercalciuria, normomagnesemia, and low bone mineral density. J Clin Endocrinol Metab. 2002; 87: 3248-54.
34. Torpy DJ, Gordon RD, Lin JP et al. Familial hyperaldosteronism type II: description of a large kindred and exclusion of the aldosterone synthase (CYP11B2) gene. J Clin Endocrinol Metab 1998; 83: 3214-8.
35. Torpy DJ, Stratakis CA, Gordon RD. Linkage analysis of familial hyperaldosteronism type II-absence of linkage to the gene encoding the angiotensin II receptor type 1. J Clin Endocrinol Metab 1998; 83: 1046.
36. Mansfield TA, Simon DB, Farfel Z et al. Multilocus linkage of familial hyperkalaemia and hypertension, pseudohypoaldosteronism type II, to chromosomes 1q31-42 and 17p11-q21. Nat Genet 1997; 16: 202-5.
37. O'Shaughnessy KM, Fu B, Johnson A, Gordon RD. Linkage of Gordon's syndrome to the long arm of chromosome 17 in a region recently linked to familial essential hypertension. J Hum Hypertens 1998; 12: 675-8.
38. Disse-Nicodeme S, Achard JM, Desitter I et al. A new locus on chromosome 12p13.3 for pseudohypoaldosteronism type II, an autosomal dominant form of hypertension. Am J Hum Genet 2000; 67: 302-10.
39. Lafferty AR, Torpy DJ, Stowasser M et al. A novel genetic locus for low renin hypertension: familial hyperaldosteronism type II maps to chromosome 7 (7p22). J Med Genet 2000; 37: 831-5.
40. Disse-Nicodeme S, Desitter I, Fiquet-Kempf B et al. Genetic heterogeneity of familial hyperkalaemic hypertension. J Hypertens 2001; 19: 1957-64.
41. Wilson FH, Disse-Nicodeme S, Choate KA et al. Human hypertension caused by mutations in WNK kinases. Science 2001; 293: 1107-12.
42. Verissimo F, Jordan P. WNK kinases, a novel protein kinase subfamily in multi-cellular organisms. Oncogene 2001; 20: 5562-9.
43. Wilson FH, Kahle KT, Sabath E et al. Molecular pathogenesis of inherited hypertension with hyperkalemia: the Na-Clcotransporter is inhibited by wildtype but not mutant WNK. Proc Natl Acad Sci USA 2003; 100: 680-4.
44. Yang CL, Angell J, Mitchell R, Ellison DH. WNK kinases regulate thiazide-sensitive Na-Cl cotransporter. J Clin Invest 2003; 111: 1039-45.
45. Vantyghem MC, Evrard A, Hober C, Wemeau JL, J Lefebvre. Les hypoaldostéronismes de l'adulte. Rev Fr Endocrinol Clin Nutr Metab 1997; 4-5: 119-126
46. Rodriguez-Soriano J. New insights into the pathogenesis of renal tubular acidosis-from functional to molecular studies. Pediatr Nephrol 2000; 14: 1121-36.